Gold Silver Reports (GSR) – Cipla Shares Decline As Regulatory Concerns Prevail At Pithampur Unit – Shares of the drug maker fell as much as 2.9 percent to Rs 572.15. The pharmaceutical company received three observations from the U.S. drug regulator for its Pithampur unit, according to its exchange filing.
Cipla trades at 45.7 times trailing 12-month earnings per share and 28 times its estimates for the coming year. The stock has declined 6 percent so far this year.
Start Of Next Bull Run For TCS: N Chandrasekaran On TCS Entering $100 Billion Club
⭐ Deal wins have been fully integrated into the company
⭐ Digital transformation has aided company’s growth
⭐ TCS is in extremely good position, engaging with clients on digital transformation
